chr20-32762102-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The variant allele was found at a frequency of 0.533 in 151,490 control chromosomes in the GnomAD database, including 23,419 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.53   (  23419   hom.,  cov: 31) 
Consequence
 Unknown 
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.270  
Publications
65 publications found 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76). 
BP6
Variant 20-32762102-T-C is Benign according to our data. Variant chr20-32762102-T-C is described in ClinVar as Benign. ClinVar VariationId is 1170166.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.902  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|
Frequencies
GnomAD3 genomes  0.533  AC: 80679AN: 151372Hom.:  23386  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
80679
AN: 
151372
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.533  AC: 80764AN: 151490Hom.:  23419  Cov.: 31 AF XY:  0.540  AC XY: 39929AN XY: 73992 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
80764
AN: 
151490
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
39929
AN XY: 
73992
show subpopulations 
African (AFR) 
 AF: 
AC: 
29566
AN: 
41414
American (AMR) 
 AF: 
AC: 
8472
AN: 
15232
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1501
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
4746
AN: 
5136
South Asian (SAS) 
 AF: 
AC: 
3149
AN: 
4800
European-Finnish (FIN) 
 AF: 
AC: 
4524
AN: 
10472
Middle Eastern (MID) 
 AF: 
AC: 
94
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
27290
AN: 
67672
Other (OTH) 
 AF: 
AC: 
989
AN: 
2100
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.513 
Heterozygous variant carriers
 0 
 1781 
 3562 
 5343 
 7124 
 8905 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 686 
 1372 
 2058 
 2744 
 3430 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2556
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency    Benign:1 
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.